CoChat

Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence

Vierhout, Megan, Ayoub, Anmar, Naiel, Safaa, Yazdanshenas, Parichehr, Revill, Spencer D., Reihani, Amir, Dvorkin‐Gheva, Anna, Shi, Wei, Ask, Kjetil · 2021 · Wound Repair and Regeneration
Cited by 81

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Since the discovery of the myofibroblast over 50 years ago, much has been learned about its role in wound healing and fibrosis. Its origin, however, remains controversial, with a number of progenitor cells being proposed. Macrophage–myofibroblast transition (MMT) is a recent term coined in 2014 that describes the mechanism through which macrophages, derived from circulating monocytes originating in the bone marrow, transformed into myofibroblasts and contributed to kidney fibrosis. Over the past years, several studies have confirmed the existence of MMT in various systems, suggesting that MMT could potentially occur in all fibrotic conditions and constitute a reasonable therapeutic target to prevent progressive fibrotic disease. In this perspective, we examined recent evidence supporting the notion of MMT in both human disease and experimental models across organ systems. Mechanistic insight from these studies and information from in vitro studies is provided. The findings substantiating plausible MMT showcased the co‐expression of macrophage and myofibroblast markers, including CD68 or F4/80 (macrophage) and α‐SMA (myofibroblast), in fibroblast‐like cells. Furthermore, fate‐mapping experiments in murine models exhibiting myeloid‐derived myofibroblasts in the tissue further provide direct evidence for MMT. Additionally, we provide some evidence from single cell RNA sequencing experiments confirmed by fluorescent in situ hybridisation studies, showing monocyte/macrophage and myofibroblast markers co‐expressed in lung tissue from patients with fibrotic lung disease. In conclusion, MMT is likely a significant contributor to myofibroblast formation in wound healing and fibrotic disease across organ systems. Circulating precursors including monocytes and the molecular mechanisms governing MMT could constitute valid targets and provide insight for the development of novel antifibrotic therapies; however, further understanding of these processes is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/wrr.12946

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 81

Metadata

Authors
Vierhout, M., Ayoub, A., Naiel, S., Yazdanshenas, P., Revill, S. D., Reihani, A., Dvorkin‐Gheva, A., Shi, W., & Ask, K.
Venue
Wound Repair and Regeneration
Publisher
Wiley
Published
2021-06-09
Volume
29
Issue
4
Pages
548-562
ISSN
  • 1067-1927 (ISSN-L)
  • 1524-475X
OpenAlex
W3172470241
Cited by
81
References
11
FWCI
5.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence. https://app.cochat.ai/papers/10.1111/wrr.12946
The paper
Vierhout, M., Ayoub, A., Naiel, S., Yazdanshenas, P., Revill, S. D., Reihani, A., Dvorkin‐Gheva, A., Shi, W., & Ask, K. (2021). Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence. Wound Repair and Regeneration. https://doi.org/10.1111/wrr.12946

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.